Lotensin HCT (Validus Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Lotensin HCT drug offered from Validus Pharmaceuticals LLC. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Validus Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | benazepril hydrochloride and hydrochlorothiazide |
| SUBSTANCE NAME: | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1992-05-30 |
| END MARKETING DATE: | 0000-00-00 |
Lotensin HCT HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lotensin HCT from Validus Pharmaceuticals LLC |
| LABELER NAME: | Validus Pharmaceuticals LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 1992-05-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 30698-452_294af145-7f9b-4872-b2a4-84fa49494b35 |
| PRODUCT NDC: | 30698-452 |
| APPLICATION NUMBER: | NDA020033 |
Other BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
